Stock listing
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
Selected listing: 002393 · SZSE · CNY · CN
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A (Shenzhen:002393), Health Technology. Latest release Apr 24, 2026: Tianjin Development Says Tianjin Lisheng…
- Ticker
- Shenzhen:002393
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
The company specializes in the pharmaceutical industry, focusing on the development and production of various medical products. As part of its commitment to healthcare, Lisheng aims to enhance the quality of life through innovative solutions.
Latest news from Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
April 23, 2026
Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
March 24, 2026
Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
March 9, 2026
Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
January 23, 2026
Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co
October 23, 2025
Research Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Tianjin Lisheng Pharmaceutical Co., Ltd. Class A on 6ix.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Tianjin Lisheng Pharmaceutical Co., Ltd. Class A.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Tianjin Lisheng Pharmaceutical Co., Ltd. Class A.